Write in a clean editor, then format for Cancer Pathogenesis and Therapy in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Cancer Pathogenesis and Therapy is a peer-reviewed journal published by Elsevier, covering Cancer Immunotherapy and Biomarkers, Diverse Scientific and Economic Studies, Lung Cancer Treatments and Mutations.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Cancer Pathogenesis and Therapy 12 (2023) 45–58.
Formats any DOI in Cancer Pathogenesis and Therapy style. No sign-up. |
| Publishes research in | Cancer Immunotherapy and Biomarkers Diverse Scientific and Economic Studies Lung Cancer Treatments and Mutations Ferroelectric and Negative Capacitance Devices Big Data and Digital Economy |
| ISSN | 2949-7132 |
| Citation impact (2-yr) | 5.48 |
| h-index | 20 |
| i10-index | 41 |
| Total citations | 1,541 |
| Open access | Yes |
| Top institutions publishing here | Chinese PLA General Hospital |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Skin cancer is one of the most prevalent cancers in the world, and its incidence and mortality rates are increasing continuously, mostly in regions with white-skinned inhabitants. The types of skin cancer vary in their origin and clinical appearances and also differ in their extensiveness. The continents of the world have different scenarios of skin…
Immunotherapies boosting the immune system's ability to target cancer cells are promising for the treatment of various tumor types, yet clinical responses differ among patients and cancers. Recently, there has been increasing interest in novel cancer immunotherapy practices aimed at triggering T cell-mediated anti-tumor responses. Antigen-directed cytotoxicity mediated by T lymphocytes has become a central…
One in six deaths worldwide is caused by cancer, making it a major global health concern. Despite their effectiveness, traditional treatment approaches such as radiation therapy, chemotherapy, and surgery frequently have negative side effects and high costs. New approaches, such as gene therapy, are promising but are hampered by high costs and accessibility problems. Nanoparticles…
Small cell lung cancer (SCLC) is a highly aggressive tumor type for which limited therapeutic progress has been made. Platinum-based chemotherapy with or without thoracic radiotherapy remains the backbone of treatment, but most patients with SCLC acquire therapeutic resistance. Given the need for more effective therapies, better elucidation of the molecular pathogenesis of SCLC is…
Platinum-based chemotherapy, a cornerstone in the treatment of various malignancies, is often limited by its potential cardiotoxic effects. Understanding these effects is crucial for optimizing patient outcomes and guiding treatment decisions. This review explores the mechanisms, clinical manifestations, detection, management, and future directions in the research of cardiotoxicity associated with platinum-based chemotherapy. The mechanisms discussed…
